Jonathan V. Dixon's most recent trade in Bionano Genomics Inc was a trade of 25 Common Stock done at an average price of $3.7 . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bionano Genomics Inc | Jonathan V. Dixon | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.68 per share. | 03 Jun 2025 | 25 | 269 (0%) | 0% | 3.7 | 92 | Common Stock |
| Bionano Genomics Inc | Jonathan V. Dixon | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 6,559 | 6,559 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Jonathan V. Dixon | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.67 per share. | 15 Feb 2025 | 6 | 294 (0%) | 0% | 5.7 | 34 | Common Stock |
| Bionano Genomics Inc | Jonathan V. Dixon | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 68,000 | 68,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Jonathan V. Dixon | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 14,500 | 18,025 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | Jonathan V. Dixon | GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.27 per share. | 15 Feb 2024 | 402 | 3,525 (0%) | 0% | 1.3 | 511 | Common Stock |